関連する実験動画
Updated: Jul 14, 2026

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
結核に対するDOTSの直接観察コンポーネントの有効性: パキスタンのランダム化対照試験
J D Walley1, M A Khan, J N Newell
1Nuffield Institute for Health, University of Leeds, UK. j.d.walley@leeds.ac.uk
Lancet (London, England)
|March 15, 2001
まとめ
結核 (TB) の直接観察された治療戦略は,医療従事者または家族によって観察されたか,または自己投与によって観察されたかに関わらず,同様の治癒率を示しました. 直接観察された治療の有効性を明らかにするためにさらなる研究が必要である.
科学分野:
- 公衆衛生は公衆衛生である.
- 感染症 感染症は感染症です.
- クリニック・トライアル 臨床試験
背景:
- 世界保健機関 (WHO) は,結核管理のための世界的な戦略として,直接観察された短期治療 (DOTS) を推進しています.
- パキスタンの国家結核プログラムでは,現地状況に適した治療法の直接観察に関する証拠に基づいたガイドラインが必要です.
- パキスタンの運用条件下で,異なる結核治療戦略を評価するために,ランダム化試験が行われました.
研究 の 目的:
- パキスタンのさまざまな結核治療の提供戦略の有効性を評価する.
- DOTSを医療従事者の観察,DOTSを家族の観察,および自己投与治療と比較するために.
- パキスタンの国立結核プログラムに指針を提供すること.
主な方法:
- 新しい唾液陽性結核を患った497人の成人を対象としたランダム化試験.
- 参加者は3つのグループに分けられ,保健医療従事者が観察したDOTS,家族が観察したDOTS,または自己投与された治療でした.
- 治療には,治療と治療の完了を主なアウトカムとして,8ヶ月間にわたって標準的な毎日の短期薬剤レジメンが含まれていました.
主要な成果:
- 治癒率は3つの戦略でほぼ同じでした:医療従事者のDOTSでは64%,家族のDOTSでは55%,自己投与治療では62%でした.
- 治癒または治療の完了率は,医療従事者のDOTSでは67%であり,家族のDOTSでは62%であり,自己投与治療では65%であった.
- テストされた戦略の間で,統計的に有意な結果の違いは観察されなかった.
結論:
- 評価された治療戦略のいずれも,治癒率の観点から,他の治療戦略よりも優位性を示しませんでした.
- この研究では,治療の直接観察は,自己投与と比較して治癒率のさらなる改善をもたらさなかった.
- 直接観察された治療の有効性は,運用研究を通じてさらなる調査を必要とします.
関連する概念動画
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

